Chronic Disease
Featured Topics
Lead story
Other featured articles
-
Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes
Though the study of racially diverse Medicaid patients indicated disproportionate risk among Latinos, USC researchers say it can’t be explained by higher rates of poverty or underlying health factors like obesity.
Posted in -
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
A new white paper published by the USC Schaeffer Center focuses on multi-cancer, early detection, (MCED) blood-based tests as one solution to reduce disparities in late-stage cancer diagnosis among minority populations.
Posted in -
Measuring Real-World Effectiveness and Value
Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints. Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial.
Posted in -
Leveraging Precision Medicine to Meet Patient Needs
Precision medicine promises to reduce adverse side effects and time-consuming trial and error processes, but many patients do not know what it is and providers struggle to leverage it effectively.
Posted in
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Categorized in -
Congress Should End Dialysis Companies’ Third-Party Games with Insurance Coverage
A new op-ed in STAT highlights practices by dialysis facilities where they try to push patients into individual market plans by financing patients’ premiums for those plans
-
How Sick Is My Cohort Of Patients? A General Approach to Identify Chronic Conditions
This presentation discusses a SAS(r) macro that applies Chronic Conditions Warehouse-like rules to any data set either from insurance claims, or electronic health records (EHR) containing a full picture of diagnoses and procedures from patient medical visits.
Categorized in -
Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability
Is an intensive lifestyle intervention for type 2 diabetes associated with long-term health care use and Medicare spending?
Categorized in -
Making Progress in Cancer Diagnostics: Clinical Practice and Policy
Join the Health, Medicine and Society Program of the Aspen Institute and the USC Schaeffer Center for a webinar on new clinical advances in cancer screening and the policy issues surrounding access to and adoption of these advances.
-
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
The researchers examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient’s zip code–level race/ethnicity or income.
Categorized in